New name reflects evolution of company from development-stage biotech to innovator in predictive medicine TORONTO, Sept. 27...
CDN$10 million/US$8.2 million financing positions IMI for future anticipated growth TORONTO, Aug. 30 /PRNewswire-FirstCall/ -- Predictive...
Enters into agreement for CDN$10 million/US$8.2 million TORONTO, Aug. 18 /PRNewswire-FirstCall/ -- Predictive medicine company IMI International...
- Major ColorectAlert(TM) study with U.S. National Cancer Institute - 25,000-participant PREPARE study underway in life insurance testing market...
Allstate teams up with IMI and McNeil Consumer Healthcare for non-invasive risk assessments TORONTO, Aug. 2 /PRNewswire-FirstCall/ -- Blood...
New data validates PREVU(x) LT Skin Sterol Test Lab-processed format of PREVU(x) reliably measures skin sterol TORONTO, July 26...
Skin sterol linked to history of coronary events TORONTO, July 25 /PRNewswire-FirstCall/ -- Skin tissue cholesterol is strongly associated with...
IMI announces major clinical trial with ColorectAlert(TM) - Sponsored by U.S. National Cancer Institute's EDRN - Patented painless, low-cost...
IMI comments on market activity and Prevu(x) progress TORONTO, June 30 /PRNewswire-FirstCall/ -- In response to recent trading activity in the...
IMI announces three new skin sterol patents TORONTO, June 21 /PRNewswire-FirstCall/ -- Leading predictive medicine company IMI International...
Skin sterol correlates with presence of coronary calcium Simple, non-invasive test an effective tool to identify early heart disease TORONTO, June...
IMI plans change in name to PreMD Inc. New name reflects evolution of company from development-stage biotech to innovator in predictive medicine...
New skin sterol data to be presented at American Association for Clinical Chemistry meeting TORONTO, May 24 /PRNewswire-FirstCall/ -- Predictive...
IMI announces first quarter financial results and provides operational update - Lead cardiovascular test, PREVU(x) POC, made available for sale...
PREVU(x) study to open new markets PREVU(x) LT Skin Sterol Test included in 25,000-participant insurance industry study TORONTO, May 10...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.